Haleon Value Chain Analysis

Haleon Value Chain Analysis

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

Haleon Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Dive Deeper Into the Activities Behind the Analysis

This Haleon Value Chain Analysis helps you quickly understand how the company creates value through its support and primary activities in a clear, structured format. This page already shows a real preview of the analysis, so you can review the actual content before buying. Purchase the full version to get the complete ready-to-use report.

Support Activities

Icon

Firm Infrastructure

Haleon's firm infrastructure supports a global consumer healthcare platform in more than 100 markets, so governance, compliance, treasury, and portfolio control stay tight across regions. In FY2025, that matters most for OTC claims, product registrations, and recall readiness, where one control failure can hit many markets at once. Centralized brand, pricing, and supply oversight helps Haleon keep decisions consistent across regulated categories.

Icon

Human Resource Management

Haleon's human resource management matters because it supports a workforce of about 22,000 people across more than 170 markets, where brands like Sensodyne, Panadol, and Centrum need technical, regulatory, and commercial skills. Hiring and training help keep product quality high and protect scientific credibility in pharmacies, retail, and digital channels. Strong people management also helps Haleon retain product and compliance know-how, which is vital for fast market-by-market execution.

Explore a Preview
Icon

Technology Development

Haleon's technology development in FY2025 focused on formulation, clinical evidence, packaging design, and digital commerce, which supports 4 core areas: oral health, pain relief, respiratory health, and vitamins, minerals, and supplements. This work helps Haleon speed launches, add line extensions, and meet regulatory needs while protecting trust in brands like Sensodyne, Panadol, and Centrum.

Icon

Procurement

Haleon procurement secures active ingredients, excipients, packaging, contract services, and plant inputs at scale, so supply continuity stays tight across high-volume brands. Because consumer healthcare products face strict quality and regulatory checks, supplier qualification, audit trails, and dual sourcing matter as much as price. Strong sourcing helps Haleon protect availability, margin, and batch consistency when input costs or lead times move.

Icon
Icon

Haleon's Global Backbone: 22,000 People Supporting 100+ Markets

Haleon's support activities in FY2025 were built to run a regulated global portfolio across 100+ markets and about 170 markets of people and execution. Its 22,000-strong workforce, tight governance, and R&D in oral health, pain relief, respiratory, and vitamins help keep launches, compliance, and brand trust aligned. Procurement and supply controls also matter because one supplier or quality slip can affect many markets fast.

FY2025 metric Value
Markets served 100+
Workforce ~22,000
People footprint 170 markets

What is included in the product

Word Icon Detailed Word Document
Provides a clear framework for analyzing Haleon's support activities and core value-creating operations
Plus Icon
Excel Icon Editable Excel File
Provides a clear Haleon Value Chain Analysis to quickly identify pain points, streamline core activities, and support faster value-creation decisions.

Primary Activities

Icon

Inbound Logistics

In FY2025, Haleon kept its inbound logistics focused on active ingredients, vitamins, packaging, and other inputs from a global supplier base. Tight supplier controls cut quality risk and help keep OTC medicines and supplements consistent at scale. This matters because even one stockout can hit pharmacy and retail shelf space fast, so inventory planning has to stay sharp.

Icon

Operations

Haleon's Operations turn sourced inputs into finished consumer healthcare products through formulation, blending, filling, packing, and quality testing. In 2025, that factory discipline supported 4 core categories and helped protect its 25.7% adjusted operating margin on about £11.2bn revenue. Tight plant control and quality systems matter here because every batch must deliver the same brand promise, meet rules, and keep waste low.

Explore a Preview
Icon

Outbound Logistics

Haleon ships finished goods to distributors, wholesalers, pharmacies, retailers, and e-commerce partners, so outbound logistics directly shapes shelf availability and online fill rates. In FY2024, Haleon reported £11.2 billion in net revenue, and keeping service levels high helps protect that scale by reducing stockouts on fast-moving brands like Sensodyne and Panadol. Strong execution also matters because consumer healthcare buys are convenience-led: if a product is missing in store or online, shoppers switch fast.

Icon

Marketing and Sales

Haleon's marketing and sales engine is built on brand-led promotion, pharmacy ties, retail trade programs, and digital channels, with science-backed claims doing the heavy lifting in low-involvement, repeat-buy categories. Strong consumer awareness helps Haleon protect shelf space, convert category leadership into pricing power, and speed adoption of new products. In FY2025, that matters because small gains in repeat purchase and trade visibility can move a large base of everyday health sales.

Icon

Service

Haleon's service work centers on consumer support, product information, complaint handling, and safety monitoring, which matters most in regulated health categories where trust can move repeat purchase. Clear labels and usage guidance help customers use products correctly, while fast issue resolution and post-sale follow-up feed quality feedback back into operations. That support loop protects brand credibility and helps keep service costs tied to fewer escalations and safer product use.

Icon

Haleon's FY2025 execution drove £11.2bn revenue and 25.7% margin

In FY2025, Haleon's primary activities turned trusted OTC and wellness brands into scale: inbound inputs, factory control, and distribution kept supply steady across pharmacies, retailers, and online channels. Marketing and sales leaned on science-backed brand demand, while service handled consumer support and safety feedback. With about £11.2bn revenue and a 25.7% adjusted operating margin, execution across the chain stayed value-critical.

FY2025 metric Value
Revenue £11.2bn
Adjusted operating margin 25.7%

Full Version Awaits
Haleon Reference Sources

This is the actual Haleon Value Chain Analysis document you'll receive upon purchase – no surprises, just professional quality. The preview below is taken directly from the full report, so what you see is exactly what you get. Buy now to unlock the complete, in-depth version immediately after checkout.

Explore a Preview

Frequently Asked Questions

Marketing and operations drive the most value. Haleon sells in more than 100 markets and concentrates on 4 core categories, so brand demand and execution both matter. Since the 2022 spin-off, Haleon has leaned on scale, trusted brands, and disciplined supply to convert consumer trust into repeat purchases and stable margins.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.